Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon
September 17, 2015
Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today ...
Tags
Press Releases
APRI
AKRX
From
Benzinga
Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon
September 17, 2015
Apricus Reaffirms Plans to Move RayVa Into Late-Stage Clinical Trials in Patients With Scleroderma Who Also Suffer From Raynaud's Phenomenon
From
GlobeNewswire News Releases
Morning Market Gainers
September 10, 2015
Envivio Inc (NASDAQ: ENVI) shares jumped 113.16 percent to $4.05 after the company agreed to be acquired by Ericsson (ADR) (NASDAQ: ...
Tags
Market Gainers
ERIC
News
From
Benzinga
Apricus Biosciences Enters Into License Agreement With Allergan for the U.S. Rights to Vitaros
September 10, 2015
Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today ...
Tags
News
Benzinga
Press Releases
From
Benzinga
Apricus Biosciences Enters Into License Agreement With Allergan for the U.S. Rights to Vitaros(TM)
September 10, 2015
Apricus to Lead Clinical and Regulatory Efforts; Allergan Retains Commercialization Option in U.S.
From
GlobeNewswire News Releases
Apricus Biosciences to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
September 02, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Italy by Bracco SpA
September 01, 2015
From
GlobeNewswire News Releases
Mid-Day Market Update: Thursday's Movers, Feds Meet But No Answers Met
August 20, 2015
The U.S. stock market tumbled for the third straight day after growth worries manifest investors’ thoughts. The Federal Reserve ...
Tags
ACI
News
Benzinga
From
Benzinga
Apricus Biosciences Announces it is Seeking a Global Partner for Femprox, a Novel Treatment for Female Sexual Dysfunction
August 19, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries
August 10, 2015
Vitaros Now Approved in Twenty-Two Countries in Europe Under the Decentralized Procedure
From
GlobeNewswire News Releases
Apricus Biosciences Provides Corporate Update and Second Quarter 2015 Financial Results
August 05, 2015
From
GlobeNewswire News Releases
Apricus Biosciences to Present at the Canaccord Genuity 35th Annual Growth Conference
August 05, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Announces Corporate Update and Second Quarter 2015 Financial Results Conference Call
July 30, 2015
From
GlobeNewswire News Releases
Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
July 09, 2015
From
PR Newswire
US Stock Futures Signal Lower Start On Wall Street
June 15, 2015
Pre-open movers US stock futures traded lower in early pre-market trade. The Empire State manufacturing for June will be released ...
Tags
News
ONCY
SAIC
From
Benzinga
Apricus Biosciences Announces Last Patient Enrolled in RayVa Phase 2a Clinical Trial for Raynaud's Phenomenon in Patients With Scleroderma
June 15, 2015
Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today ...
Tags
FDA
Benzinga
News
From
Benzinga
Apricus Biosciences Announces Last Patient Enrolled in RayVa(TM) Phase 2a Clinical Trial for Raynaud's Phenomenon in Patients With Scleroderma
June 15, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial for Fispemifene in Men With Symptomatic Secondary Hypogonadism
June 01, 2015
Topline Data Expected in the First Quarter of 2016
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in France by Laboratoires Majorelle
May 28, 2015
To Be Commercialized in France as Vitaros(R)
From
GlobeNewswire News Releases
Apricus Biosciences Provides Corporate Update and First Quarter 2015 Financial Results
May 11, 2015
Conference Call / Webcast Today, Monday, May 11, 2015 at 8:30 a.m. ET
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Spain by Recordati
May 06, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Announces Corporate Update and First Quarter 2015 Financial Results Conference Call
May 04, 2015
Conference Call and Webcast to be Held on Monday, May 11, 2015 at 8:30 a.m. ET
From
GlobeNewswire News Releases
Apricus Biosciences to Present at Two Investor Conferences in May
April 28, 2015
From
GlobeNewswire News Releases
Apricus Biosciences, Inc. to Present at Taglich Brothers 12th Annual Investment Conference
April 20, 2015
From
Marketwired News Releases
Ritter Pharmaceuticals Names Paul V. Maier to its Board of Directors
April 14, 2015
From
Business Wire News Releases
Apricus Biosciences Provides Corporate Update and 2014 Year-End Financial Results
March 16, 2015
Conference Call / Webcast Today, Monday, March 16, 2015 at 8:30 a.m. ET
From
GlobeNewswire News Releases
Apricus Biosciences Announces Corporate Update and Fourth Quarter and Year-End 2014 Financial Results Conference Call
March 09, 2015
Conference Call and Webcast to be Held Monday, March 16, 2015 at 8:30 a.m. ET
From
GlobeNewswire News Releases
Apricus Biosciences to Present at the 27th Annual Roth Conference
March 04, 2015
From
GlobeNewswire News Releases
SeeThruEquity Initiates Coverage on Apricus Biosciences, Inc. with Price Target of $4.22
March 04, 2015
From
ACCESSWIRE
10 cheapest stocks in the Nasdaq’s hottest sector
February 25, 2015
A handful of health-care stocks have doubled this year, and one has quadrupled, writes Phil van Doorn.
Tags
Health/Care
Medical Products
General
From
MarketWatch
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.